Uk Ophthalmic Devices Market: Market Size & Forecast 2026

The UK ophthalmic devices market encompasses a broad range of diagnostic imaging systems, surgical equipment, intraocular lenses, vision care products, and associated consumables used in ophthalmology and optometry. Valued at $2.18 billion in 2025, the market sits within a broader UK medical devices sector estimated at $19.07 billion, and represents a significant portion of the European ophthalmic devices market valued at approximately $11.5 billion. No official UK government body such as the Office for National Statistics publishes standalone market valuation figures for this niche device category.

• •Market valued at $2.18 billion in 2025 with a 9% projected CAGR through 2031
• •Part of a broader UK medical devices market of approximately $19.07 billion
• •Represents a major share of the European ophthalmic devices sector valued at roughly $11.5 billion

A primary growth catalyst is the rising burden of chronic eye disease: epidemiological data indicates that over one million adults in the UK are living with glaucoma, while conditions such as diabetic retinopathy and age-related macular degeneration are increasing in prevalence alongside an aging demographic. The UK's National Health Service continues to prioritize ophthalmology care pathways, supporting investment in advanced diagnostic technologies such as optical coherence tomography. Patient awareness and demand for refractive surgery, cataract procedures, and premium intraocular lens options in both public and private care settings further underpin market expansion.

• •Over one million UK adults live with glaucoma, creating sustained demand for diagnostic and surgical device solutions
• •NHS ophthalmology service pressures drive investment in high-throughput diagnostic equipment
• •Growing demand for cataract and refractive surgery procedures fuels the intraocular lens and surgical device segments

The UK ophthalmic devices market is segmented into surgical devices, diagnostic and monitoring devices, vision care, and implants and consumables. Within the diagnostic and monitoring category, optical coherence tomography scanners are identified as the leading product segment in 2025. The UK market is broadly recognized as one of Europe's leading national markets for ophthalmic devices, alongside Germany and France, supported by a highly developed healthcare infrastructure and one of the largest publicly funded ophthalmology services in Europe.

• •Optical coherence tomography scanners are the top product segment within the diagnostic device category
• •Key segments include surgical devices, diagnostic and monitoring equipment, vision care products, and intraocular implants
• •The UK is positioned among Europe's leading national markets, alongside Germany and France

What are the recent trends and outlook?

Key trends shaping the UK market include the accelerating adoption of digital and AI-assisted diagnostic tools, integration of OCT and fundus imaging into routine NHS screening pathways, and increasing demand for minimally invasive surgical technologies. The transition toward personalized and premium intraocular lenses for cataract surgery is expanding the high-value implant segment. Looking ahead to 2031, the market is expected to maintain a compound annual growth rate near 9%, supported by continued disease burden growth, NHS technology procurement cycles, and expanding private healthcare options.

• •AI-enhanced diagnostic imaging and automated screening tools are increasingly integrated into NHS ophthalmology pathways
• •Premium and multifocal intraocular lenses represent a growing high-margin segment within cataract surgery
• •The market is projected to sustain approximately 9% annual growth through 2031, driven by demographic and clinical demand factors